Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Introduction to Epidemiology01:26

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Sampling Methods: Overview01:06

Sampling Methods: Overview

A sample refers to a smaller subset representative of a larger population. In analytical chemistry, studying or analyzing an entire population is often impractical or impossible. Therefore, samples are used to draw inferences and generalize the whole population. The sampling method selects individuals or items from a population to create a sample. Standard sampling methods include random, judgemental, systematic, stratified, and cluster sampling. 
In analytical chemistry, the choice of sampling...
Overview of Biostatistics in Health Sciences01:19

Overview of Biostatistics in Health Sciences

Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Responsible Research Practices in Pediatrics: How Reporting Guidelines Can Be Used to Improve Trial Design and Conduct.

The Journal of pediatrics·2026
Same author

SPIRIT 2025 statement: updated guideline for protocols of randomised trials.

Lancet (London, England)·2026
Same author

SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols.

The Lancet. Child & adolescent health·2026
Same author

CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials.

The Lancet. Child & adolescent health·2026
Same author

Updating the PRISMA reporting guideline for scoping reviews: a scoping review.

Journal of clinical epidemiology·2026
Same author

PRISMA-Children and Adolescents (PRISMA-C) 2026 extension statement and explanation: enhancing the reporting and utility of systematic reviews of interventions in paediatrics.

BMJ (Clinical research ed.)·2026
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

Small sample approach, and statistical and epidemiological aspects.

Martin Offringa1, Hanneke van der Lee

  • 1Department of Paediatric Clinical Epidemiology, Emma Children's Hospital, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. m.offringa@amc.uva.nl

Handbook of Experimental Pharmacology
|September 2, 2011
PubMed
Summary
This summary is machine-generated.

Designing pediatric drug trials requires careful consideration of pharmacokinetic studies and phase III trials. Novel approaches like population pharmacokinetics and adaptive trial designs can reduce sample sizes and improve efficiency in pediatric drug research.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 29, 2026

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Pediatric clinical trial design
  • Pharmacokinetics and pharmacodynamics
  • Drug development in children

Background:

  • Pediatric drug research presents unique challenges, including ethical considerations and the need for efficient study designs.
  • Traditional pharmacokinetic studies often involve burdensome blood sampling, impacting pediatric participants.
  • Ensuring the ethical and scientific rigor of pediatric clinical trials is paramount.

Purpose of the Study:

  • To discuss classical and novel approaches for designing pharmacokinetic studies and phase III trials in children.
  • To explore methods for overcoming challenges in pediatric drug research, such as minimizing sample sizes and managing sparse data.
  • To provide an overview of adaptive trial designs and the role of Data Monitoring Committees (DMCs) in pediatric trials.

Main Methods:

  • Population pharmacokinetics modeling for analyzing sparse data in pediatric pharmacokinetic studies.
  • Review of classical strategies and advanced designs (group sequential, boundaries, adaptive) to minimize sample sizes.
  • Examination of Data Monitoring Committee (DMC) activities, interim analyses, and early trial termination.

Main Results:

  • Population pharmacokinetics offers a statistical solution for sparse data, reducing the burden of repeated blood sampling.
  • Adaptive and sequential designs demonstrate significant sample size reductions (35-70%) compared to classical methods.
  • Current reporting of DMC activities and interim analyses in pediatric trials is often incomplete and heterogeneous.

Conclusions:

  • Novel pharmacokinetic and trial designs can enhance the efficiency and ethical conduct of pediatric drug research.
  • Adaptive and sequential designs are effective in reducing sample size requirements for pediatric trials.
  • Standardized reporting of DMC activities and interim analyses is crucial to prevent misleading interpretations of pediatric trial results.